By Caroline White1998-05-21T00:00:00
With the US pharmaceutical giants targeting the elusive UK market, the issue of whether drug companies should be able to advertise their wares direct to the public is more pertinent than ever. Caroline White reports
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud